The cost-effective probabilities of gefitinib arm for 31 provinces of Chinese mainland.
收藏数据链接：
官方服务：
资源简介：
aConsist of Tianjin, Shanghai, Beijing, Jiangsu, Zhejiang and Inner Mongolia.bConsist of Jilin, Chongqing, Hubei, Hebei, Shanxi, Ningxia, Heilongjiang, Shangxi, Xinjiang, Hunan, Qinghai, Henan, Hainan, Jiangxi, Sichuan, Guangxi, Anhui, Tibet, Gansu, Yuannan and Guizhou.
创建时间：
2015-12-02
